• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来西亚绝经后乳腺癌患者辅助内分泌治疗的应用

Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia.

作者信息

Saiful Bahri Athirah, Tuan Mahmood Tuan Mazlelaa, Abdul-Aziz Siti Azdiah, Makmor-Bakry Mohd, Mohamed Shah Noraida

机构信息

Centre of Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

出版信息

Patient Prefer Adherence. 2021 Feb 3;15:227-235. doi: 10.2147/PPA.S293029. eCollection 2021.

DOI:10.2147/PPA.S293029
PMID:33568899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7868301/
Abstract

CONTEXT

Globally, breast cancer is the most common cancer affecting women, and adjuvant endocrine therapy (AET) is part of its treatment modality, which improves patients' outcome. However, there are concerns on side effects related to its use, which may affect treatment adherence.

PURPOSE

This study was conducted to explore attitude and practice on using AET among breast cancer patients in Malaysia.

PATIENTS AND METHODS

Postmenopausal breast cancer patients on at least 3 months of AET attending the outpatient oncology clinic at a tertiary care hospital were interviewed. Patients underwent in-depth interviews exploring their attitude and practices while on AET using a semi-structured interview guide. The interviews were transcribed verbatim and analyzed using thematic analysis.

RESULTS

There were four main themes for attitude toward the use of AET: 1) benefits of using AET, 2) concerns on taking AET, 3) beliefs on alternative treatment, and 4) beliefs toward the doctor. For practice, six themes were obtained: 1) correct use of AET, 2) appointment adherence, 3) information-seeking behavior, 4) counseling services obtained, 5) experienced side effects of AET, and 6) usage of complementary and alternative medicines.

CONCLUSION

Several themes concerning attitude and practice of breast cancer patients receiving AET were identified, which may be addressed during treatment consultations in clinical practice.

摘要

背景

在全球范围内,乳腺癌是影响女性的最常见癌症,辅助内分泌治疗(AET)是其治疗方式的一部分,可改善患者的治疗效果。然而,人们担心其使用带来的副作用,这可能会影响治疗依从性。

目的

本研究旨在探讨马来西亚乳腺癌患者对使用AET的态度和行为。

患者与方法

对在一家三级护理医院门诊肿瘤诊所接受至少3个月AET治疗的绝经后乳腺癌患者进行访谈。患者使用半结构化访谈指南接受深入访谈,探讨他们在接受AET治疗时的态度和行为。访谈内容逐字记录,并采用主题分析法进行分析。

结果

对使用AET的态度有四个主要主题:1)使用AET的益处,2)对接受AET的担忧,3)对替代治疗的看法,4)对医生的看法。在行为方面,得到了六个主题:1)正确使用AET,2)遵守预约,3)信息寻求行为,4)获得的咨询服务,5)经历的AET副作用,6)补充和替代药物的使用。

结论

确定了几个关于接受AET的乳腺癌患者态度和行为的主题,在临床实践的治疗咨询中可能需要解决这些问题。

相似文献

1
Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia.马来西亚绝经后乳腺癌患者辅助内分泌治疗的应用
Patient Prefer Adherence. 2021 Feb 3;15:227-235. doi: 10.2147/PPA.S293029. eCollection 2021.
2
Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women.乳腺癌辅助内分泌治疗的依从性:绝经后妇女症状归因的定性探讨。
Support Care Cancer. 2024 Apr 2;32(4):265. doi: 10.1007/s00520-024-08463-w.
3
Women with breast cancer's perceptions of nurse-led telephone-based motivational interviewing consultations to enhance adherence to adjuvant endocrine therapy: a qualitative study.乳腺癌女性对护士主导的基于电话的动机性访谈咨询以增强辅助内分泌治疗依从性的看法:一项定性研究。
Support Care Cancer. 2022 Jun;30(6):4759-4768. doi: 10.1007/s00520-021-06692-x. Epub 2022 Feb 8.
4
The Patient's Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer.患者的声音:乳腺癌辅助内分泌治疗的依从性、症状与痛苦
Int J Behav Med. 2020 Dec;27(6):687-697. doi: 10.1007/s12529-020-09908-2.
5
Optimization of an Information Leaflet to Influence Medication Beliefs in Women With Breast Cancer: A Randomized Factorial Experiment.优化信息传单以影响乳腺癌女性的药物信念:一项随机析因实验。
Ann Behav Med. 2023 Oct 16;57(11):988-1000. doi: 10.1093/abm/kaad037.
6
Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.解析乳腺癌幸存者启动、维持或终止辅助内分泌治疗的决策:一项混合方法研究。
Oncol Nurs Forum. 2017 May 1;44(3):E101-E110. doi: 10.1188/17.ONF.E101-E110.
7
Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis.探索医生就辅助内分泌治疗与正在接受治疗的乳腺癌患者沟通的作用:一项定性分析。
Support Care Cancer. 2017 Jan;25(1):75-83. doi: 10.1007/s00520-016-3389-6. Epub 2016 Aug 24.
8
Women's Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions.女性对乳腺癌辅助内分泌治疗早期依从性的信念:一项基于理论的定性研究,以指导社区药剂师干预措施的制定。
Pharmacy (Basel). 2018 Jun 9;6(2):53. doi: 10.3390/pharmacy6020053.
9
Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors.探讨社会支持和辅助内分泌治疗在乳腺癌幸存者中的作用。
Support Care Cancer. 2020 Jan;28(1):271-278. doi: 10.1007/s00520-019-04814-0. Epub 2019 Apr 29.
10
Health belief about adjuvant endocrine therapy in premenopausal breast cancer survivors: a qualitative study.绝经前乳腺癌幸存者对辅助内分泌治疗的健康认知:一项定性研究。
Patient Prefer Adherence. 2019 Sep 9;13:1519-1525. doi: 10.2147/PPA.S217562. eCollection 2019.

引用本文的文献

1
Validation and reliability of the Bahasa Malaysia language version of the Acceptance of Illness Scale among Malaysian patients with cancer.马来语版疾病接受度量表在马来西亚癌症患者中的验证和可靠性。
PLoS One. 2021 Sep 29;16(9):e0256216. doi: 10.1371/journal.pone.0256216. eCollection 2021.

本文引用的文献

1
The association between patients' preferred treatment after the use of a patient decision aid and their choice of eventual treatment.患者使用患者决策辅助工具后首选的治疗方法与最终选择的治疗方法之间的关联。
Health Expect. 2020 Jun;23(3):651-658. doi: 10.1111/hex.13045. Epub 2020 Mar 13.
2
Information Received and Usefulness of the Sources of Information to Cancer Patients at a Tertiary Care Centre in Malaysia.马来西亚一家三级护理中心的癌症患者所获得的信息及信息来源的有用性。
J Cancer Educ. 2021 Apr;36(2):350-358. doi: 10.1007/s13187-019-01637-9.
3
A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy.老年乳腺癌幸存者对内分泌治疗相关治疗信息处理方式的定性比较。
PLoS One. 2019 Jan 31;14(1):e0210972. doi: 10.1371/journal.pone.0210972. eCollection 2019.
4
Adjuvant endocrine therapy side-effects among postmenopausal breast cancer patients in Malaysia.马来西亚绝经后乳腺癌患者辅助内分泌治疗的副作用。
Climacteric. 2019 Apr;22(2):175-181. doi: 10.1080/13697137.2018.1540563. Epub 2018 Dec 17.
5
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.激素受体阳性乳腺癌妇女的辅助内分泌治疗:ASCO 临床实践指南更新焦点。
J Clin Oncol. 2019 Feb 10;37(5):423-438. doi: 10.1200/JCO.18.01160. Epub 2018 Nov 19.
6
Use of complementary and alternative medicine and adherence to antiepileptic drug therapy among epilepsy patients: a systematic review.癫痫患者中补充和替代医学的使用及抗癫痫药物治疗的依从性:一项系统评价
Patient Prefer Adherence. 2018 Oct 11;12:2111-2121. doi: 10.2147/PPA.S179031. eCollection 2018.
7
Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer.早期乳腺癌患者辅助内分泌治疗 10 年与 5 年的临床结局比较。
BMC Cancer. 2018 Oct 12;18(1):977. doi: 10.1186/s12885-018-4878-4.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
The impact of a prescription review and prescriber feedback system on prescribing practices in primary care clinics: a cluster randomised trial.处方审核与开方者反馈系统对基层医疗诊所开方行为的影响:一项整群随机试验
BMC Fam Pract. 2018 Jul 19;19(1):120. doi: 10.1186/s12875-018-0808-4.
10
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer.早期乳腺癌中延长辅助内分泌治疗的现状。
Curr Treat Options Oncol. 2018 Apr 27;19(5):26. doi: 10.1007/s11864-018-0541-1.